Advertisement
 
YOU ARE HERE: LAT HomeCollectionsPacific Biometrics Inc
IN THE NEWS

Pacific Biometrics Inc

BUSINESS
January 29, 1998
Pacific Biometrics Inc.: The Irvine provider of diagnostics and laboratory services reported a net loss of $941,055, or 25 cents a share, for the second fiscal quarter ended Dec. 31, compared with a net loss of $306,435, or 10 cents a share, for the comparable period in fiscal 1997. Revenue increased by 34% to $871,290 from $648,437.
Advertisement
BUSINESS
January 7, 1998 | Dow Jones
Pacific Biometrics Inc. said it has acquired the rights to Sudormed Inc.'s skin patch technology for $3 million. Pacific Biometrics said Tuesday that it will pay Sudormed over a 15-month period. Under the agreement, Pacific Biometrics also agreed to make an ongoing royalty payment based on the sales of products developed from the technology. Pacific Biometrics said the license agreement also allows for all other potential applications, except for those relating to alcohol and drug abuse.
BUSINESS
September 10, 1997
Pacific Biometrics Inc., which develops diagnostics and laboratory services to detect and manage chronic diseases, reported narrower losses for the fiscal year ended June 30. The company incurred a net loss of $1.6 million, or 51 cents a share, for the fiscal year, compared with a net loss of $7.6 million, or $5.89 a share, for the prior year. Revenue increased 65% to $2.8 million from $1.7 million.
BUSINESS
May 13, 1997
Pacific Biometrics Inc., which develops diagnostic products for chronic diseases, said it lost $439,026, or 12 cents a share, for the third fiscal quarter, compared to a net loss of $147,443, or 9 cents a share, for the year-earlier period. Revenue for the quarter ended March 31 increased 60% to $648,550 from $404,145. For the nine months, the company lost $1.
BUSINESS
November 1, 1996
Pacific Biometrics Inc. said its initial public offering of 1.7 million units was priced at $4.75 a unit, generating about $8.1 million for the company, which develops diagnostic and laboratory products in the fields of cardiovascular disease and osteoporosis. The units consist of one share of common stock and one warrant, which are separated as the units are issued.
Los Angeles Times Articles
|